| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24158200P | 2000-10-19 | 2000-10-19 |
| Publication Number | Publication Date |
|---|---|
| ECSP034558Atrue ECSP034558A (en) | 2003-06-25 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2003004558AECSP034558A (en) | 2000-10-19 | 2003-04-17 | STROGEN RECEIVER MODULATORS |
| Country | Link |
|---|---|
| EP (1) | EP1333827A2 (en) |
| JP (1) | JP2004511502A (en) |
| KR (1) | KR20030042020A (en) |
| CN (1) | CN1469743A (en) |
| AU (2) | AU3238102A (en) |
| BG (1) | BG107676A (en) |
| BR (1) | BR0114689A (en) |
| CA (1) | CA2424729A1 (en) |
| EA (1) | EA200300474A1 (en) |
| EC (1) | ECSP034558A (en) |
| EE (1) | EE200300153A (en) |
| HU (1) | HUP0303563A2 (en) |
| IL (1) | IL154984A0 (en) |
| IS (1) | IS6761A (en) |
| MX (1) | MXPA03003485A (en) |
| NO (1) | NO20031737L (en) |
| PE (1) | PE20021083A1 (en) |
| PL (1) | PL361053A1 (en) |
| SK (1) | SK4772003A3 (en) |
| WO (1) | WO2002032377A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030225132A1 (en)* | 2002-04-11 | 2003-12-04 | Dininno Frank P. | Estrogen receptor modulators |
| EP1501819B1 (en)* | 2002-04-24 | 2010-09-15 | Merck Sharp & Dohme Corp. | Estrogen receptor modulators |
| BR0308901A (en) | 2002-05-10 | 2005-01-04 | Hoffmann La Roche | bisphosphonic acids for osteoporosis treatment and prevention |
| CA2512000C (en)* | 2002-12-26 | 2011-08-09 | Eisai Co., Ltd. | Selective estrogen receptor modulator |
| AU2006275514B2 (en)* | 2005-07-29 | 2012-04-05 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| EP1944301A4 (en)* | 2005-10-27 | 2012-01-04 | Msd Kk | NEW BENZOXATHINE DERIVATIVE |
| CN101641339B (en) | 2007-02-01 | 2013-07-17 | 雷斯韦洛吉克斯公司 | Compounds for the prevention and treatment of cardiovascular diseases |
| EP2382194B1 (en) | 2009-01-08 | 2014-03-12 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
| US9238640B2 (en) | 2009-03-18 | 2016-01-19 | Resverlogix Corp. | Anti-inflammatory agents |
| EP3431086B1 (en) | 2009-04-22 | 2020-06-17 | Resverlogix Corp. | Novel anti-inflammatory agents |
| PL2580210T3 (en) | 2010-06-10 | 2017-09-29 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
| WO2011159769A2 (en) | 2010-06-17 | 2011-12-22 | Aragon Pharmaceuticals, Inc. | Indane estrogen receptor modulators and uses thereof |
| HUE044986T2 (en) | 2011-11-01 | 2019-11-28 | Resverlogix Corp | Oral immediate release formulations for substituted quinazolinones |
| WO2013090829A1 (en) | 2011-12-14 | 2013-06-20 | Aragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| JP2016507496A (en) | 2012-12-21 | 2016-03-10 | ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． | Novel heterocyclic compounds as bromodomain inhibitors |
| JP6903585B2 (en) | 2015-03-13 | 2021-07-14 | レスバーロジックス コーポレイション | Compositions and Therapeutic Methods for the Treatment of Complement-Related Diseases |
| Publication number | Publication date |
|---|---|
| WO2002032377A2 (en) | 2002-04-25 |
| MXPA03003485A (en) | 2003-07-14 |
| JP2004511502A (en) | 2004-04-15 |
| AU3238102A (en) | 2002-04-29 |
| HUP0303563A2 (en) | 2004-03-01 |
| EE200300153A (en) | 2003-06-16 |
| SK4772003A3 (en) | 2003-08-05 |
| CA2424729A1 (en) | 2002-04-25 |
| PE20021083A1 (en) | 2002-12-16 |
| KR20030042020A (en) | 2003-05-27 |
| WO2002032377A3 (en) | 2002-08-22 |
| EP1333827A2 (en) | 2003-08-13 |
| CN1469743A (en) | 2004-01-21 |
| IS6761A (en) | 2003-03-27 |
| NO20031737D0 (en) | 2003-04-15 |
| IL154984A0 (en) | 2003-10-31 |
| BG107676A (en) | 2003-11-28 |
| NO20031737L (en) | 2003-06-19 |
| AU2002232381B2 (en) | 2004-11-18 |
| PL361053A1 (en) | 2004-09-20 |
| EA200300474A1 (en) | 2003-10-30 |
| BR0114689A (en) | 2003-07-01 |
| Publication | Publication Date | Title |
|---|---|---|
| ECSP034558A (en) | STROGEN RECEIVER MODULATORS | |
| BG105967A (en) | C(7) ester substituted taxanes and their use as antitumor agents | |
| DOP2001000151A (en) | IMIDAZOPIRIMIDINE DERIVATIVES AND TRIAZOLOPIMIDINE DERIVATIVES. | |
| DE69907977D1 (en) | Pyrrolobenzodiazepine | |
| TR200202194T2 (en) | Polyglutamic acid-camptothecin compounds and preparation methods | |
| ECSP045245A (en) | N-ARIL-2-OXAZOLIDINONA-5-CARBOXAMIDS AND ITS DERIVATIVES | |
| DE60135919D1 (en) | FARNESYL TRANSFERASE-INHIBITING 6-HETEROCYCLYLMETHYL-CHINOLINE AND CHINAZOLE DERIVATIVES | |
| PA8522701A1 (en) | COMPOUNDS OF BENCENIC ACETAMIDS THAT ARE ACTIVATORS OF GLUCOKINASE a-ACILO-Y a-HETEROATOMO-REPLACED | |
| JO2410B1 (en) | Substituted 6-pyrido-pyrimidines | |
| PE20020108A1 (en) | STRUCTURES AND COMPOSITIONS THAT INCREASE THE STABILITY OF PEROXIDE ASSETS | |
| PA8567001A1 (en) | ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS | |
| HN2002000235A (en) | FORMULATIONS IN COMBINATION OF DERIVATIVES OF 1, 4 - BENZOTHYPINE - 1, 1 - DIOXIDE WITH OTHER ACTIVE SUBSTANCES, AND THEIR USE | |
| PA8553101A1 (en) | FORMULATIONS IN COMBINATION OF PROPANOL-AMINA DERIVATIVES SUBSTITUTED WITH ARILO, TOGETHER WITH OTHER ACTIVE SUBSTANCES AND ITS USE | |
| ES2189657B1 (en) | PESTICIDE RESIN COMPOSITIONS. | |
| PA8543701A1 (en) | PHENYL-HETEROCICLIL-ETERES | |
| MY128164A (en) | Compounds | |
| GT199900037A (en) | NEW HERBICIDE COMPOSITIONS. | |
| BR0313400A (en) | N-aryl-2-oxazolidinones and their derivatives | |
| ATE401325T1 (en) | C10-CARBAMOYLOXY SUBSTITUTED TAXANES AS ANTI-TUMOR AGENTS | |
| DK1165549T3 (en) | C7 carbamoyloxy-substituted taxanes as antitumor agents | |
| DE50212676D1 (en) | EXOPOLYSACCHARIDPRODUKTION | |
| DOP2000000050A (en) | ANTI-COLOR COMPOSITION | |
| BR0113202A (en) | Trioxepane compounds | |
| ECSP045116A (en) | COMPOSITION OF STABILIZED TRANSPARENT SOAP | |
| HN2000000197A (en) | COMBINATION TREATMENT WITH 11 - 1RA AND COMPOUNDS THAT INHIBIT THE PROCESSING AND RELEASE OF 11 - 1. |